Piper Sandler analyst Jessica Tassan downgraded Oak Street Health (OSH) to Neutral from Overweight with a price target of $39, down from $47, after CVS Health (CVS) announced the acquisition of Oak Street for $39 per share in cash or $10.6B. The analyst downgrades the shares based on the deal terms.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on OSH: